Sema4.ai Analysis: $568M Raised
What is Sema4.ai?
Sema4.ai specializes in enterprise AI agents that automate complex business processes. Their platform integrates with existing systems to enhance productivity and efficiency. This approach allows organizations to tackle high-value tasks that traditional automation cannot manage effectively.
Employees
51-200
Founded
2024
Industry
SaaS, AI/ML, Cloud Infrastructure
Product Features & Capabilities
- Enterprise AI Agent Platform for building and scaling agents
- Docker Desktop integration for secure server access
- Control Room for managing agents on cloud infrastructure
- Work Room for user-friendly agent interaction
- Document Intelligence for understanding various document types.
Use Cases
Automate invoice reconciliation to save man-hours; Ensure regulatory compliance with real-time updates; Match receivables to invoices with high accuracy; Enhance customer service through efficient task management; Streamline supply chain operations with intelligent agents.
How much Sema4.ai raised
Post IPO - $200M
May 02, 2022Lead Investor: Pfizer
Series C - $121M
July 29, 2020Lead Investor: BlackRock, Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng, Connecticut Innovation Fund
Series B - $127.61M
August 22, 2019Lead Investor: Connecticut Innovations, Decheng, Mount Sinai Health System, Oak HC/FT
Series A-2 - $64.25M
March 21, 2018Lead Investor: Undisclosed Investors
Series A-1 - $55M
March 21, 2018Lead Investor: Undisclosed Investors
Other Considerations
Notable clients include leading global companies; Integrates with Docker for enhanced deployment; Focuses on high-ROI automation beyond traditional RPA.
See something that needs updating? Suggest edits to this profile.
Financial Overview
$568MTotal Raised
Post IPO$200M
May 02, 2022
Investors: Pfizer
Series C$121M
July 29, 2020
Investors: BlackRock, Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng, Connecticut Innovation Fund
Series B$127.61M
August 22, 2019
Investors: Connecticut Innovations, Decheng, Mount Sinai Health System, Oak HC/FT
Series A-2$64.25M
March 21, 2018
Investors: Undisclosed Investors
Series A-1$55M
March 21, 2018
Investors: Undisclosed Investors
